Innate Pharma (IPHA) Enterprise Value (2019 - 2026)
Innate Pharma (IPHA) posted Enterprise Value of $159.78 million for the quarter ended Jun 30, 2026, up 127.4% from $70.26 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Enterprise Value (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at Innate Pharma was -$48.79 million; for the year ended Dec 31, 2025, it was $125.24 million, up 87.4% from the prior year.
- Annual Enterprise Value shows a five-year compound annual growth rate of -16.2% (years ended Dec 2020 to Dec 2025).
- In prior years, Innate Pharma's Enterprise Value was $66.83 million in the year ended Dec 31, 2024 (-68.1%), $209.72 million in the year ended Dec 31, 2023 (-23.4%), $273.66 million in the year ended Dec 31, 2022 (-19.0%) and $337.72 million in the year ended Dec 31, 2021 (+11.3%).
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Enterprise Value since the quarter ended Dec 31, 2023.
- On a year-over-year basis, Enterprise Value increased in three of the last four quarters, with growth averaging 41.7%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was the quarter ended Jun 30, 2026, with growth of 127.4%; the weakest was the quarter ended Dec 31, 2024, with a decline of 67.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.00 Mn |
| Dec 31, 2025 | 123.70 Mn |
| Jun 30, 2025 | 82.17 Mn |
| Dec 31, 2024 | 70.20 Mn |
| Jun 30, 2024 | 57.78 Mn |
| Dec 31, 2023 | 122.94 Mn |
| Jun 30, 2023 | 148.39 Mn |
| Dec 31, 2022 | 188.50 Mn |
| Jun 30, 2022 | 85.91 Mn |
| Dec 31, 2021 | 227.00 Mn |
| Jun 30, 2021 | 117.85 Mn |
| Dec 31, 2020 | 136.54 Mn |
| Jun 30, 2020 | 372.11 Mn |
| Dec 31, 2019 | 260.88 Mn |
API Access
Innate Pharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();